The global azithromycin injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Azithromycin injection is used to treat certain bacterial infections, such as bronchitis, pneumonia, sexually transmitted diseases, and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs. The global azithromycin injection market is growing due to the rising prevalence of bacterial infection globally. The article of the World Health Organization (WHO), published in November 2021, declared that bacterial infection is one of the top 10 global public health threats. According to an article published by the Centre for Disease Control and Prevention in 2019, more than 2.8 million bacterial infections occur in the US each year, and more than 35,000 people die as a result.
The rising prevalence of pneumonia globally is also driving the growth of the market. According to WHO, pneumonia accounts for 14% of all deaths of children under 5 years old and killed 740,180 children in 2019. Additionally, azithromycin injection was also prescribed by health professionals in certain countries for the treatment of COVID-19 is also boosting the demand for azithromycin injection. Furthermore, the improved healthcare infrastructure, as well as huge investment by major market players for research and development activities, are also driving the growth of the global azithromycin injection market.
The North American region is anticipated to hold the major share in the global azithromycin injection market. This is due to the higher prevalence of fungal infection in this region along with advanced healthcare infrastructure. This region is also known for its early adoption of new treatments which will also drive the growth of the market. Additionally, the presence of major market players like Mylan N.V., and Pfizer Inc. in this region is also anticipated to drive the growth of the North American azithromycin injection market during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Azithromycin Injection Market at: https://orionmarketreports.com/request-sample/?id=104578&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Mylan N.V., Pfizer Inc., Cipla Inc., and Teva Pharmaceutical Industries Ltd., among others.
A full report Azithromycin Injection Market of is available at: https://orionmarketreports.com/azithromycin-injection-market/104578/
Global Azithromycin injection Market Report by Segment
By Application
- Hospital
- Clinics
- Recovery Center
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
